Search research articles
Contact Us
Filters
Showing results (281-290 of 426) with videos related to
Page
of 43
Sort By:
Bulletin of the International Union Against Tuberculosis and Lung Disease
|
June 1, 1990
A modern approach to the immunotherapy of tuberculosis
J L Stanford, G M Bahr, P Byass, et al.
Journal of Ovarian Research
|
August 2, 2011
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
Yi Yu, Seby L Edassery, Animesh Barua, et al.
Neonatology
|
February 10, 2020
Improving the Bilirubin Management Program in the Newborn Nursery: Background, Aims, and Protocol
Timothy M Bahr, Julie H Shakib, Carole H Stipelman, et al.
Tubercle
|
September 1, 1986
Skin sensitization to mycobacteria amongst school children prior to a study of BCG vaccination in North Lebanon
G M Bahr, J L Stanford, G A Rook, et al.
Tubercle
|
December 1, 1988
Recognition of a category of responders to group II, slow-grower associated antigens amongst Kuwaiti senior school children, using a statistical model
I C McManus, D N Lockwood, J L Stanford, et al.
Tubercle
|
September 1, 1986
Two potential improvements to BCG and their effect on skin test reactivity in the Lebanon
G M Bahr, J L Stanford, G A Rook, et al.
Clinical Chemistry
|
February 5, 2000
Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C
R Lichtinghagen, O Huegel, T Seifert, et al.
European Journal of Immunology
|
July 13, 2001
Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4
V F Vidal, N Castéran, C J Riendeau, et al.
The Journal of Infectious Diseases
|
December 8, 1998
Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression
C Amiel, E Darcissac, M J Truong, et al.
Clinical and Experimental Immunology
|
May 5, 1998
Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD)
T Idziorek, J Khalife, O Billaut-Mulot, et al.
Page
of 43
Search research articles
Search
Showing results (281-290 of 426) with videos related to
Sort By:
Page
of 43
Bulletin of the International Union Against Tuberculosis and Lung Disease
|
June 1, 1990
A modern approach to the immunotherapy of tuberculosis
J L Stanford, G M Bahr, P Byass, et al.
Journal of Ovarian Research
|
August 2, 2011
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
Yi Yu, Seby L Edassery, Animesh Barua, et al.
Neonatology
|
February 10, 2020
Improving the Bilirubin Management Program in the Newborn Nursery: Background, Aims, and Protocol
Timothy M Bahr, Julie H Shakib, Carole H Stipelman, et al.
Tubercle
|
September 1, 1986
Skin sensitization to mycobacteria amongst school children prior to a study of BCG vaccination in North Lebanon
G M Bahr, J L Stanford, G A Rook, et al.
Tubercle
|
December 1, 1988
Recognition of a category of responders to group II, slow-grower associated antigens amongst Kuwaiti senior school children, using a statistical model
I C McManus, D N Lockwood, J L Stanford, et al.
Tubercle
|
September 1, 1986
Two potential improvements to BCG and their effect on skin test reactivity in the Lebanon
G M Bahr, J L Stanford, G A Rook, et al.
Clinical Chemistry
|
February 5, 2000
Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C
R Lichtinghagen, O Huegel, T Seifert, et al.
European Journal of Immunology
|
July 13, 2001
Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4
V F Vidal, N Castéran, C J Riendeau, et al.
The Journal of Infectious Diseases
|
December 8, 1998
Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression
C Amiel, E Darcissac, M J Truong, et al.
Clinical and Experimental Immunology
|
May 5, 1998
Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD)
T Idziorek, J Khalife, O Billaut-Mulot, et al.
Page
of 43